Business Description
Omega Healthcare Investors Inc
NAICS : 531120
SIC : 6798
ISIN : US6819361006
Share Class Description:
STU:WX4: Ordinary SharesDescription
Omega Healthcare Investors Inc is a healthcare facility real estate investment trust that invests in the United States real estate markets. Omega's portfolio focuses on long-term healthcare facilities. Omega has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 1.26 | |||||
| Debt-to-EBITDA | 5.27 | |||||
| Interest Coverage | 2.37 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.32 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 2.1 | |||||
| 3-Year EPS without NRI Growth Rate | 3.3 | |||||
| 3-Year FCF Growth Rate | -2.9 | |||||
| 3-Year Book Growth Rate | -4.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 13.48 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.33 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.11 | |||||
| 9-Day RSI | 75.7 | |||||
| 14-Day RSI | 71.72 | |||||
| 6-1 Month Momentum % | 24.5 | |||||
| 12-1 Month Momentum % | 16.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.54 | |||||
| Quick Ratio | 5.54 | |||||
| Cash Ratio | 0.1 | |||||
| Days Sales Outstanding | 80.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 6.43 | |||||
| Dividend Payout Ratio | 2.1 | |||||
| Forward Dividend Yield % | 6.46 | |||||
| 5-Year Yield-on-Cost % | 6.53 | |||||
| 3-Year Average Share Buyback Ratio | -2 | |||||
| Shareholder Yield % | 5.19 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 98.5 | |||||
| Operating Margin % | 55.76 | |||||
| Net Margin % | 33.52 | |||||
| FCF Margin % | 68.73 | |||||
| ROE % | 9.05 | |||||
| ROA % | 3.58 | |||||
| ROIC % | 6.2 | |||||
| 3-Year ROIIC % | -5.77 | |||||
| ROC (Joel Greenblatt) % | 2216.23 | |||||
| ROCE % | 6.55 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-FFO | 17.51 | |||||
| PE Ratio | 31.73 | |||||
| Forward PE Ratio | 27.3 | |||||
| PE Ratio without NRI | 32.63 | |||||
| Shiller PE Ratio | 25.51 | |||||
| Price-to-Owner-Earnings | 19.31 | |||||
| PS Ratio | 10.97 | |||||
| PB Ratio | 2.85 | |||||
| Price-to-Tangible-Book | 3.45 | |||||
| Price-to-Free-Cash-Flow | 15.96 | |||||
| Price-to-Operating-Cash-Flow | 15.96 | |||||
| EV-to-EBIT | 26.47 | |||||
| EV-to-Forward-EBIT | 22.16 | |||||
| EV-to-EBITDA | 17.34 | |||||
| EV-to-Forward-EBITDA | 13.84 | |||||
| EV-to-Revenue | 15.7 | |||||
| EV-to-Forward-Revenue | 15.8 | |||||
| EV-to-FCF | 22.85 | |||||
| Price-to-Projected-FCF | 1.29 | |||||
| Price-to-Median-PS-Value | 1.34 | |||||
| Price-to-Graham-Number | 2.24 | |||||
| Earnings Yield (Greenblatt) % | 3.78 | |||||
| FCF Yield % | 6.27 | |||||
| Forward Rate of Return (Yacktman) % | 4.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Omega Healthcare Investors Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 904.875 | ||
| EPS (TTM) (€) | 1.215 | ||
| Beta | -0.08 | ||
| Volatility % | 17.75 | ||
| 14-Day RSI | 71.72 | ||
| 14-Day ATR (€) | 0.461104 | ||
| 20-Day SMA (€) | 37.102 | ||
| 12-1 Month Momentum % | 16.01 | ||
| 52-Week Range (€) | 25.55 - 38.71 | ||
| Shares Outstanding (Mil) | 257.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Omega Healthcare Investors Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Omega Healthcare Investors Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Omega Healthcare Investors Inc Frequently Asked Questions
What is Omega Healthcare Investors Inc(STU:WX4)'s stock price today?
The current price of STU:WX4 is €38.38. The 52 week high of STU:WX4 is €38.71 and 52 week low is €25.55.
When is next earnings date of Omega Healthcare Investors Inc(STU:WX4)?
The next earnings date of Omega Healthcare Investors Inc(STU:WX4) is 2024-10-30.
Does Omega Healthcare Investors Inc(STU:WX4) pay dividends? If so, how much?
The Dividend Yield %  of Omega Healthcare Investors Inc(STU:WX4) is 6.43% (As of Today), Highest Dividend Payout Ratio of Omega Healthcare Investors Inc(STU:WX4) was 4.01. The lowest was 1.14. And the median was 1.68. The  Forward Dividend Yield % of Omega Healthcare Investors Inc(STU:WX4) is 6.46%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers